ESC 365 - EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes

Open Access

EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes

Session: Hot Line EMPEROR-Reduced

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor M. Packer (Dallas, US)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

42 presentations

4 followers

2 more presentations in this session

Hot Line EMPEROR-Reduced.

Speaker: Professor B. Casadei (Oxford, GB) Professor R. De Boer (Rotterdam, NL) Doctor M. Packer (Dallas, US) Professor M. Metra (Brescia, IT)

EMPEROR-Reduced - LIVE PRIME TIME DISCUSSION.

Access the full session

Hot Line EMPEROR-Reduced

Speakers: Doctor M. Packer, Professor B. Casadei, Professor R. De Boer, Doctor M. Packer, Professor M. Metra

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

ESC Premium Access

Triglycerides: the underestimated player.

27 August 2021

ESC Premium Access

Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA)

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

ESC 365 is supported by